Literature DB >> 2473065

High molecular weight insulin-like growth factor binding protein complex. Purification and properties of the acid-labile subunit from human serum.

R C Baxter1, J L Martin, V A Beniac.   

Abstract

In the human circulation, the insulin-like growth factors (IGFs) circulate as part of a growth hormone-dependent 125- to 150-kDa complex. This complex has been postulated to contain, in addition to IGFs and one or more IGF-binding proteins, an acid-labile subunit (ALS) which does not itself bind IGFs. In this study, the ALS has been purified 1600-fold from human serum, and its binding properties have been examined. Fresh serum was fractionated on DEAE-Sephadex, and active fractions (determined by radioimmunoassay) were purified by affinity chromatography on an IGF-agarose column saturated with the plasma IGF-binding protein BP-53. After further high performance anion exchange chromatography, an ALS preparation was obtained which contained only an 84-86-kDa protein doublet, converting to a single 70-kDa band on N-glycanase treatment, and having an amino-terminal sequence unrelated to IGF-binding proteins or receptors. Pure ALS formed a complex with BP-53 (Ka approximately 5 x 10(8) M-1), immunoprecipitable by anti-BP-53 antiserum, only in the presence of IGF-I or IGF-II. This complex appeared at approximately 150 kDa on high performance gel chromatography. Pure ALS had no intrinsic IGF-binding activity and no effect on the binding of IGF-I or IGF-II to BP-53. These studies suggest that formation of the high molecular weight IGF-binding protein complex requires ALS, BP-53, and IGF.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473065

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.

Authors:  H Yu; J Mistry; M J Nicar; M J Khosravi; A Diamandis; J van Doorn; A Juul
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

Review 2.  The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders.

Authors:  Jesse Costales; Alexander Kolevzon
Journal:  Neurosci Biobehav Rev       Date:  2016-01-15       Impact factor: 8.989

3.  Organization and chromosomal localization of the gene encoding the mouse acid labile subunit of the insulin-like growth factor binding complex.

Authors:  Y R Boisclair; D Seto; S Hsieh; K R Hurst; G T Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

4.  Investigation of an albumin-enriched fraction of human serum and its albuminome.

Authors:  Rebekah L Gundry; Qin Fu; Christine A Jelinek; Jennifer E Van Eyk; Robert J Cotter
Journal:  Proteomics Clin Appl       Date:  2007-01-01       Impact factor: 3.494

5.  Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls.

Authors:  Mary Jo Fidler; David D Shersher; Jeffrey A Borgia; Philip Bonomi
Journal:  Ther Adv Med Oncol       Date:  2012-03       Impact factor: 8.168

Review 6.  The complexity of the IGF1 gene splicing, posttranslational modification and bioactivity.

Authors:  Anastassios Philippou; Maria Maridaki; Spiros Pneumaticos; Michael Koutsilieris
Journal:  Mol Med       Date:  2014-05-07       Impact factor: 6.354

7.  The IGF system in a case of Costello syndrome.

Authors:  A Barreca; M Cotellessa; M Boschetti; A Giannattasio; L Cresta; C Schiaffino; R Lorini
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

8.  Influence of promoter region variants of insulin-like growth factor pathway genes on the strength-training response of muscle phenotypes in older adults.

Authors:  Brian D Hand; Matthew C Kostek; Robert E Ferrell; Matthew J Delmonico; Larry W Douglass; Stephen M Roth; James M Hagberg; Ben F Hurley
Journal:  J Appl Physiol (1985)       Date:  2007-08-30

Review 9.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

Review 10.  Insulin-like growth factor system regulates oligodendroglial cell behavior: therapeutic potential in CNS.

Authors:  Daniel Chesik; Jacques De Keyser; Nadine Wilczak
Journal:  J Mol Neurosci       Date:  2008-02-26       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.